These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
215 related articles for article (PubMed ID: 22362582)
1. The influence of health and lifestyle characteristics on the relation of serum 25-hydroxyvitamin D with risk of colorectal and breast cancer in postmenopausal women. Neuhouser ML; Manson JE; Millen A; Pettinger M; Margolis K; Jacobs ET; Shikany JM; Vitolins M; Adams-Campbell L; Liu S; LeBlanc E; Johnson KC; Wactawski-Wende J Am J Epidemiol; 2012 Apr; 175(7):673-84. PubMed ID: 22362582 [TBL] [Abstract][Full Text] [Related]
2. Circulating 25-Hydroxyvitamin D Concentration and Risk of Breast, Prostate, and Colorectal Cancers: The Melbourne Collaborative Cohort Study. Heath AK; Hodge AM; Ebeling PR; Eyles DW; Kvaskoff D; Buchanan DD; Giles GG; Williamson EJ; English DR Cancer Epidemiol Biomarkers Prev; 2019 May; 28(5):900-908. PubMed ID: 30842127 [TBL] [Abstract][Full Text] [Related]
3. Calcium plus vitamin D supplementation and the risk of breast cancer. Chlebowski RT; Johnson KC; Kooperberg C; Pettinger M; Wactawski-Wende J; Rohan T; Rossouw J; Lane D; O'Sullivan MJ; Yasmeen S; Hiatt RA; Shikany JM; Vitolins M; Khandekar J; Hubbell FA; J Natl Cancer Inst; 2008 Nov; 100(22):1581-91. PubMed ID: 19001601 [TBL] [Abstract][Full Text] [Related]
4. Serum 25-hydroxyvitamin D concentrations and postmenopausal breast cancer risk: a nested case control study in the Cancer Prevention Study-II Nutrition Cohort. McCullough ML; Stevens VL; Patel R; Jacobs EJ; Bain EB; Horst RL; Gapstur SM; Thun MJ; Calle EE Breast Cancer Res; 2009; 11(4):R64. PubMed ID: 19715600 [TBL] [Abstract][Full Text] [Related]
5. Plasma vitamin D metabolites and risk of colorectal cancer in women. Feskanich D; Ma J; Fuchs CS; Kirkner GJ; Hankinson SE; Hollis BW; Giovannucci EL Cancer Epidemiol Biomarkers Prev; 2004 Sep; 13(9):1502-8. PubMed ID: 15342452 [TBL] [Abstract][Full Text] [Related]
6. Re: "The influence of health and lifestyle characteristics on the relation of serum 25-hydroxyvitamin D with risk of colorectal and breast cancer in postmenopausal women". Grant WB Am J Epidemiol; 2012 Nov; 176(9):838. PubMed ID: 23045473 [No Abstract] [Full Text] [Related]
7. Serum vitamin D, vitamin D binding protein, and risk of colorectal cancer. Anic GM; Weinstein SJ; Mondul AM; Männistö S; Albanes D PLoS One; 2014; 9(7):e102966. PubMed ID: 25036524 [TBL] [Abstract][Full Text] [Related]
8. Serum vitamin D concentration and prostate cancer risk: a nested case-control study. Ahn J; Peters U; Albanes D; Purdue MP; Abnet CC; Chatterjee N; Horst RL; Hollis BW; Huang WY; Shikany JM; Hayes RB; J Natl Cancer Inst; 2008 Jun; 100(11):796-804. PubMed ID: 18505967 [TBL] [Abstract][Full Text] [Related]
9. Circulating Vitamin D Levels and Risk of Colorectal Cancer in Women. Chandler PD; Buring JE; Manson JE; Giovannucci EL; Moorthy MV; Zhang S; Lee IM; Lin JH Cancer Prev Res (Phila); 2015 Aug; 8(8):675-82. PubMed ID: 25813525 [TBL] [Abstract][Full Text] [Related]
10. Serum 25-hydroxyvitamin D, vitamin D binding protein and risk of colorectal cancer in the Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial. Weinstein SJ; Purdue MP; Smith-Warner SA; Mondul AM; Black A; Ahn J; Huang WY; Horst RL; Kopp W; Rager H; Ziegler RG; Albanes D Int J Cancer; 2015 Mar; 136(6):E654-64. PubMed ID: 25156182 [TBL] [Abstract][Full Text] [Related]
11. Association between pre-diagnostic circulating vitamin D concentration and risk of colorectal cancer in European populations:a nested case-control study. Jenab M; Bueno-de-Mesquita HB; Ferrari P; van Duijnhoven FJ; Norat T; Pischon T; Jansen EH; Slimani N; Byrnes G; Rinaldi S; Tjønneland A; Olsen A; Overvad K; Boutron-Ruault MC; Clavel-Chapelon F; Morois S; Kaaks R; Linseisen J; Boeing H; Bergmann MM; Trichopoulou A; Misirli G; Trichopoulos D; Berrino F; Vineis P; Panico S; Palli D; Tumino R; Ros MM; van Gils CH; Peeters PH; Brustad M; Lund E; Tormo MJ; Ardanaz E; Rodríguez L; Sánchez MJ; Dorronsoro M; Gonzalez CA; Hallmans G; Palmqvist R; Roddam A; Key TJ; Khaw KT; Autier P; Hainaut P; Riboli E BMJ; 2010 Jan; 340():b5500. PubMed ID: 20093284 [TBL] [Abstract][Full Text] [Related]
12. Meta-analysis of observational studies of serum 25-hydroxyvitamin D levels and colorectal, breast and prostate cancer and colorectal adenoma. Gandini S; Boniol M; Haukka J; Byrnes G; Cox B; Sneyd MJ; Mullie P; Autier P Int J Cancer; 2011 Mar; 128(6):1414-24. PubMed ID: 20473927 [TBL] [Abstract][Full Text] [Related]
13. Serum 25-hydroxyvitamin D and risk of breast cancer: results of a large population-based case-control study in Mexican women. Fedirko V; Torres-Mejía G; Ortega-Olvera C; Biessy C; Angeles-Llerenas A; Lazcano-Ponce E; Saldaña-Quiroz VA; Romieu I Cancer Causes Control; 2012 Jul; 23(7):1149-62. PubMed ID: 22622862 [TBL] [Abstract][Full Text] [Related]
14. Circulating levels of 25-hydroxyvitamin D and risk of breast cancer: a nested case-control study. Scarmo S; Afanasyeva Y; Lenner P; Koenig KL; Horst RL; Clendenen TV; Arslan AA; Chen Y; Hallmans G; Lundin E; Rinaldi S; Toniolo P; Shore RE; Zeleniuch-Jacquotte A Breast Cancer Res; 2013 Feb; 15(1):R15. PubMed ID: 23442740 [TBL] [Abstract][Full Text] [Related]
15. Dose-response of serum 25-hydroxyvitamin D in association with risk of colorectal cancer: A meta-analysis. Garland CF; Gorham ED J Steroid Biochem Mol Biol; 2017 Apr; 168():1-8. PubMed ID: 27993551 [TBL] [Abstract][Full Text] [Related]
16. Serum 25-hydroxyvitamin D and breast cancer in the military: a case-control study utilizing pre-diagnostic serum. Mohr SB; Gorham ED; Alcaraz JE; Kane CI; Macera CA; Parsons JK; Wingard DL; Horst R; Garland CF Cancer Causes Control; 2013 Mar; 24(3):495-504. PubMed ID: 23296455 [TBL] [Abstract][Full Text] [Related]
17. Serum 25-hydroxyvitamin D concentrations and lung cancer risk in never-smoking postmenopausal women. Cheng TD; Song X; Beresford SAA; Ho GYF; Johnson KC; Datta M; Chlebowski RT; Wactawski-Wende J; Qi L; Neuhouser ML Cancer Causes Control; 2017 Oct; 28(10):1053-1063. PubMed ID: 28900765 [TBL] [Abstract][Full Text] [Related]
18. Predictors of serum 25-hydroxyvitamin D concentrations among postmenopausal women: the Women's Health Initiative Calcium plus Vitamin D clinical trial. Millen AE; Wactawski-Wende J; Pettinger M; Melamed ML; Tylavsky FA; Liu S; Robbins J; LaCroix AZ; LeBoff MS; Jackson RD Am J Clin Nutr; 2010 May; 91(5):1324-35. PubMed ID: 20219959 [TBL] [Abstract][Full Text] [Related]
19. Circulating 25-hydroxyvitamin D and postmenopausal breast cancer survival: Influence of tumor characteristics and lifestyle factors? Vrieling A; Seibold P; Johnson TS; Heinz J; Obi N; Kaaks R; Flesch-Janys D; Chang-Claude J Int J Cancer; 2014 Jun; 134(12):2972-83. PubMed ID: 24272459 [TBL] [Abstract][Full Text] [Related]
20. A nested case control study of plasma 25-hydroxyvitamin D concentrations and risk of colorectal cancer. Wu K; Feskanich D; Fuchs CS; Willett WC; Hollis BW; Giovannucci EL J Natl Cancer Inst; 2007 Jul; 99(14):1120-9. PubMed ID: 17623801 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]